- NVIDIA and Abridge are collaborating to scale multilingual generative AI for clinical documentation, with NVIDIA providing compute infrastructure and foundation models.
- The partnership aims to reduce clinician workload and improve documentation quality across U.S. health systems.
- NVentures, NVIDIA's investment arm, participated as an investor in Abridge.
A Push to Automate Clinical Documentation
NVIDIA Corp. is deepening its healthcare push through a partnership with Abridge, a startup that uses ambient AI to turn doctor-patient conversations into structured clinical notes. The collaboration will leverage NVIDIA's computing infrastructure and foundation models to scale Abridge's multilingual generative AI capabilities, with the goal of easing the documentation burden on clinicians.
Abridge, which integrates with electronic health records like Epic, has been rapidly expanding its deployments across health systems. The company's technology listens to patient-clinician conversations and automatically generates draft notes, aiming to reduce cognitive load and burnout.
“We're working to bring the power of generative AI to clinical workflows in a way that is safe, accurate, and scalable,” a person familiar with the partnership said. Neither company disclosed the financial terms of the deal.
NVIDIA’s Growing Healthcare Footprint
NVIDIA has been building out its healthcare AI portfolio through partnerships with companies like Aidoc and GE HealthCare, using its GPU-accelerated platforms to power medical imaging and drug discovery. The collaboration with Abridge marks a bet on ambient clinical intelligence, a segment that has attracted investment from firms including Microsoft and venture capital funds.
The deal comes as health systems face pressure to improve efficiency without compromising care quality. Abridge’s tools are already in use at hospitals across the U.S., and the company claims its technology can save clinicians hours each day.
Looking Ahead
Short-term, the partnership is expected to speed up Abridge’s rollout within health systems, backed by NVIDIA’s AI compute scale. Longer-term, the companies aim to normalize AI-powered documentation across specialties, though regulatory hurdles around data privacy and accuracy remain.
NVIDIA’s venture arm, NVentures, participated in Abridge’s funding rounds, signaling deeper corporate alignment. Attempts to reach Abridge for additional comment were unsuccessful.
Correction: An earlier version of this article misstated the scope of NVIDIA’s investment. NVentures participated as an investor but did not lead the round.